Endothelial cell capture of heparin-binding growth factors under flow

PLoS Computational Biology

Volumn 6, Issue 10, 2010, Pages

  Zhao, Bing ^a   Zhang, Changjiang ^c   Forsten Williams, Kimberly ^b   Zhang, Jun ^c   Fannon, Michael ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Virginia Polytechnic Institute and State University   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BIOCHEMISTRY; CELL CULTURE; CONTROLLED DRUG DELIVERY; MOLECULES; POLYSACCHARIDES; PROTEINS; SULFUR COMPOUNDS; SURFACE REACTIONS; TARGETED DRUG DELIVERY;

CELL CAPTURE; COMPUTER MODELS; DELIVERY METHODS; ENDOTHELIAL-CELLS; GROWTH FACTOR; HEPARIN BINDING GROWTH FACTORS; MICROENVIRONMENTS; PREDICTED GROWTH; SYNTHETIC MOLECULES; TRADITIONAL APPROACHES;

ENDOTHELIAL CELLS;

FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; HEPARIN; PROTEOGLYCAN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARIN LYASE; PROTEOHEPARAN SULFATE; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; CAPILLARY FLOW; CELL SURFACE; CIRCULATION; COMPUTER MODEL; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW KINETICS; HOLLOW FIBER REACTOR; MATHEMATICAL MODEL; NONHUMAN; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTOR BINDING; ANIMAL; BIOLOGICAL MODEL; BIOLOGY; BIOREACTOR; CATTLE; CELL CULTURE; CELL MEMBRANE; COMPUTER SIMULATION; METABOLISM;

ANIMALS; BIOREACTORS; CATTLE; CELL MEMBRANE; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; ENDOTHELIAL CELLS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN LYASE; MODELS, CARDIOVASCULAR; PROTEIN BINDING; PROTEOGLYCANS; RECEPTORS, FIBROBLAST GROWTH FACTOR; RHEOLOGY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78349285131     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000971     Document Type: Article

References (48)

1. Hsei V, Deguzman GG, Nixon A, Gaudreault J (2002) Complexation of VEGF with bevaczumab decreases VEGF clearance in rats. Pharm Res 19: 1753-1756.
2. Kim KJ, Li B, Houck K, Winer J, Ferrara N (1992) The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7: 53-64.
3. Gordon MS, Margolin K, Talpaz M, Sledge GW, Jr., Holmgren E, et al. (2001) Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 19: 843-850.
4. Tortora GJ, Anagnostakos NP (1987) Principles of Anatomy and Physiology. New York: Harper and Row.
5. Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8: 235-253.
6. Fannon M, Forsten KE, Nugent MA (2000) Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry 39: 1434-1445.
7. Filion RJ, Popel AS (2004) A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann Biomed Eng 32: 645-663.
8. Forsten-Williams K, Chua CC, Nugent MA (2005) The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J Theor Biol 233: 483-499.
9. Ibrahimi OA, Zhang F, Hrstka SC, Mohammadi M, Linhardt RJ (2004) Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 43: 4724-4730.
10. Lovich MA, Edelman ER (1996) Computational simulations of local vascular heparin deposition and distribution. Am J Physiol 271: H2014-2024.
11. Nugent MA, Edelman ER (1992) Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry 31: 8876-8883.
12. Forsten KE, Fannon M, Nugent MA (2000) Potential mechanisms for the regulation of growth factor binding by heparin. J Theor Biol 205: 215-230.
13. Forsten-Williams K, Chu CL, Fannon M, Buczek-Thomas JA, Nugent MA (2008) Control of growth factor networks by heparan sulfate proteoglycans. Ann Biomed Eng 36: 2134-2148.
14. Gaffney EA, Heath JK, Kwiatkowska MZ (2008) A mass action model of a Fibroblast Growth Factor signaling pathway and its simplification. Bull Math Biol 70: 2229-2263.
15. Filion RJ, Popel AS (2005) Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention. Am J Physiol Heart Circ Physiol 288: H263-279.
16. Shen W, Zhang C, Fannon MW, Forsten-Williams K, Zhang J (2009) A computational model of FGF-2 binding and HSPG regulation under flow. IEEE Trans Biomed Eng 56: 2147-2155.
17. Zhang CJ, Shen WS, Zhao B, Fannon M, Forsten-Williams K, Zhang J. A Numerical Study of Pulsatile Flow Through a Hollow Fiber Cartridge: Growth Factor-Receptor Binding and Dissociation Analysis; 2009; Shanghai, China. pp 435-441.
18. Cappadona C, Redmond EM, Theodorakis NG, McKillop IH, Hendrickson R, et al. (1999) Phenotype dictates the growth response of vascular smooth muscle cells to pulse pressure in vitro. Exp Cell Res 250: 174-186.
19. Elhadj S, Mousa SA, Forsten-Williams K (2002) Chronic pulsatile shear stress impacts synthesis of proteoglycans by endothelial cells: effect on platelet aggregation and coagulation. J Cell Biochem 86: 239-250.
20. Bjornsson S (1998) Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis. Anal Biochem 256: 229-237.
21. Fannon M, Forsten-Williams K, Dowd CJ, Freedman DA, Folkman J, et al. (2003) Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment. Faseb J 17: 902-904.
22. Hornbeck RW (1964) Laminar flow in the entrance region of a pipe. Applied Science Research 13: 224-232.
23. Welty JR, Wicks CE, Wilson RE, Rorrer LG (2002) Fundamentals of Momentum, Heat, and Mass Transfer. USA: John Wiley and Sons.
24. Fannon M, Nugent MA (1996) Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate. J Biol Chem 271: 17949-17956.
25. Forsten KE, Courant NA, Nugent MA (1997) Endothelial proteoglycans inhibit bFGF binding and mitogenesis. J Cell Physiol 172: 209-220.
26. Moscatelli D (1992) Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J Biol Chem 267: 25803-25809.
27. Rapraeger AC, Krufka A, Olwin BB (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705-1708.
28. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
29. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235: 442-447.
30. Moscatelli D (1987) High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 131: 123-130.
31. Walicke PA (1988) Interactions between basic fibroblast growth factor (FGF) and glycosoaminoglycans in promoting neurite outgrowth. Exp Neurol 102: 144-148.
32. Bao X, Nishimura S, Mikami T, Yamada S, Itoh N, et al. (2004) Chondroitin sulfate/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of L-iduronic acid than those from adult pig brain, exhibit neuritogenic and growth factor binding activities. J Biol Chem 279: 9765-9776.
33. Smith SM, West LA, Govindraj P, Zhang X, Ornitz DM, et al. (2007) Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. Matrix Biol 26: 175-184.
34. Taylor KR, Rudisill JA, Gallo RL (2005) Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. J Biol Chem 280: 5300-5306.
35. Dong Z, Saliganan AD, Meng H, Nabha SM, Sabbota AL, et al. (2008) Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover. Neoplasia 10: 439-449.
36. Neuhaus W, Lauer R, Oelzant S, Fringeli UP, Ecker GF, et al. (2006) A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2. J Biotechnol 125: 127-141.
37. Stanness KA, Guatteo E, Janigro D (1996) A dynamic model of the blood-brain barrier "in vitro". Neurotoxicology 17: 481-496.
38. Herman IM, Brant AM, Warty VS, Bonaccorso J, Klein EC, et al. (1987) Hemodynamics and the vascular endothelial cytoskeleton. J Cell Biol 105: 291-302.
39. Redmond EM, Cahill PA, Sitzmann JV (1997) Flow-mediated regulation of endothelin receptors in cocultured vascular smooth muscle cells: an endothelium- dependent effect. J Vasc Res 34: 425-435.
40. Schmidt-Nielson K (1984) Scaling, why is animal size so important?. Cambridge; New York: Cambridge University Press.
41. West GB, Brown JH, Enquist BJ (1999) The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 284: 1677-1679.
42. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L (1997) Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 99: 2062-2070.
43. Tumova S, Woods A, Couchman JR (2000) Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol 32: 269-288.
44. Sasisekharan R, Moses MA, Nugent MA, Cooney CL, Langer R (1994) Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A 91: 1524-1528.
45. Kan M, Wang F, Xu J, Crabb JW, Hou J, et al. (1993) An essential heparinbinding domain in the fibroblast growth factor receptor kinase. Science 259: 1918-1921.
46. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, et al. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6: 743-750.
47. Sperinde GV, Nugent MA (2000) Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans. Biochemistry 39: 3788-3796.
48. MacGabhann F, Popel AS (2007) Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys Chem 128: 125-139.